Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The Best- And Worst-Performing Biotech Stocks July 5 To July 12
The Best- And Worst-Performing Biotech Stocks July 5 To July 12
The Best- And Worst-Performing Biotech Stocks July 5 To July 12
Submitted by
admin
on July 15, 2013 - 11:21am
Source:
Forbes
News Tags:
Vivus
Trius Therapeutics
Prosensa
Pharmacyclics
NxStage Medical
Natus Medical
MiMedx
Merrimack Pharmaceuticals
Intuitive Surgical
InterMune
GTx
Fluidigm
Epizyme
Celldex
Astex
Analogic
Amarin
Alnylam
Alexion
AcelRx
Headline:
The Best- And Worst-Performing Biotech Stocks July 5 To July 12
Do Not Allow Advertisers to Use My Personal information
